Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience

To report 15-year biochemical relapse-free survival (BRFS), cause-specific survival (CSS), and overall survival (OS) outcomes of patients treated with I(125) brachytherapy monotherapy for clinically localized prostate cancer early in the Seattle experience. Two hundred fifteen patients with clinical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of radiation oncology, biology, physics biology, physics, 2011-10, Vol.81 (2), p.376-381
Hauptverfasser:	Sylvester, John E, Grimm, Peter D, Wong, Jason, Galbreath, Robert W, Merrick, Gregory, Blasko, John C
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged BETA DECAY RADIOISOTOPES BODY BRACHYTHERAPY Brachytherapy - methods Cohort Studies DAYS LIVING RADIOISOTOPES Disease-Free Survival DISEASES ELECTRON CAPTURE RADIOISOTOPES Follow-Up Studies GLANDS HAZARDS Humans IMPLANTS INTERMEDIATE MASS NUCLEI INTERNAL CONVERSION RADIOISOTOPES IODINE 125 IODINE ISOTOPES Iodine Radioisotopes - therapeutic use ISOTOPES Male MALE GENITALS MATHEMATICS MEDICINE MULTIVARIATE ANALYSIS Neoplasm Recurrence, Local - drug therapy NEOPLASMS NUCLEAR MEDICINE NUCLEI ODD-EVEN NUCLEI ORGANS PROSTATE Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - mortality Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy RADIATION SOURCE IMPLANTS RADIATION SOURCES RADIOISOTOPES RADIOLOGY RADIOLOGY AND NUCLEAR MEDICINE RADIOTHERAPY STATISTICS THERAPY Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!